Drawing for PARFEPLIO

USPTO serial 79356458

PARFEPLIO

Reviewed by CopyMark Law Group

Reg. 7064555Status 700Registered
Filing date
Status date
Registration date
May 30, 2023
Examiner
AWRICH, ELLEN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PARFEPLIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2023GPNXNOTIFICATION PROCESSED BY IB
Jul 20, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB
Jul 20, 2023FIMPFINAL DISPOSITION PROCESSED
Jun 29, 2023GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB
May 30, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
May 30, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 14, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 14, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 22, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 9, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 8, 2023DOCKASSIGNED TO EXAMINER
Jan 20, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 20, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 20, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 20, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 20, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 20, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 13, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Dec 9, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 7, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 1, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance